SL
IART icon

Salomon & Ludwin’s Integra LifeSciences IART Stock Holding History

Salomon & Ludwin’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26K Buy
2,733
+2,480
+980% +$27.2K ﹤0.01% 896
2025
Q4 		$3.18K Sell
253
-351
-58% -$4.67K ﹤0.01% 1921
2025
Q3 		$8.94K Buy
+604
New +$8.27K ﹤0.01% 1396

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Salomon & Ludwin's IART Position: Q1 2026 in Review

Salomon & Ludwin increased its Integra LifeSciences (IART) stake by 980% in Q1 2026, buying an estimated $27.2K and bringing the position to 2,733 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Salomon & Ludwin first reported a position in IART in Q3 2025 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Salomon & Ludwin held 2,733 shares of Integra LifeSciences worth $26K as of Q1 2026.
  • Salomon & Ludwin bought 2,480 Integra LifeSciences shares in Q1 2026, an estimated $27.2K.
  • Integra LifeSciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #896 holding.
  • Salomon & Ludwin first reported a position in Integra LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.